Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Pseudoephedrine Purchases In Arkansas Require In-State Identification

This article was originally published in The Tan Sheet

Executive Summary

An Arkansas law limits sales of pseudoephedrine-containing OTC products to consumers with in-state identification, pioneering a tactic in states' attempts to curb illegal purchases.
Advertisement

Related Content

Tennessee AG Challenges Local PSE Prescription Laws
Tennessee AG Challenges Local PSE Prescription Laws
State Pseudoephedrine Legislation
Georgia Limits OTC Pseudoephedrine Sales To Pharmacies
CDER Director Sees Behind-The-Counter Switches As Best Bet
Tennessee Emerges As PSE Battleground With Rx, NPLEx Proposals
DXM Panel Proposes Augmenting, Improving Education To Curb Abuse
Mississippi PSE Prescription Switch Will Not Start An Avalanche - CHPA
Mississippi PSE Prescription Switch Will Not Start An Avalanche - CHPA
Behind-The-Counter Guidance Stalled, But Interest Grows To Expand Access

Topics

Advertisement
UsernamePublicRestriction

Register

PS104966

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel